Department of Pharmaceutics, University of Jos, Nigeria
Editorial
Inhibition of SARS-CoV-2 Replication In vitro by Losartan
Author(s): Joshua Ikoni Ogaji*
Pharmaceutical Regulatory Affairs: Open Access received 533 citations as per Google Scholar report
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 